Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Poet is like a Pharma Company in phase III waiting for FDA approval...

Poet is like a Pharma Company in phase III with a huge portfolio what is waiting for the FDA approval. Read this, change "pharma" by "POET", Novartis by Apple, J&J by Google, and so on. and think about possible POET´s partnership, finantial model, purchasing low-risk options, etc.

http://www.mckinsey.com/insights/health_systems_and_services/new_frontiers_in_pharma_r_and_38d_investment

Any differences??

GLTA

Share
New Message
Please login to post a reply